1
Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM
Condition(s):Type2diabetesLast Updated:May 9, 2023Recruiting
Continuous Subcutaneous Insulin Infusion: 267 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
CSII Versus MDI in Pregnant Women With Type 2 Diabetes
Condition(s):Type 2 Diabetes; Pregnancy in DiabeticLast Updated:November 30, 2021Not yet recruiting
3
Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice
Condition(s):Type 1 Diabetes MellitusLast Updated:January 18, 2020Completed
4
Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes
Condition(s):T2DMLast Updated:June 20, 2018Unknown status
5
A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)
Condition(s):Type 1 Diabetes MellitusLast Updated:February 1, 2019Completed
6
CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks – A Longitudinal Study
Condition(s):Type 1 DiabetesLast Updated:February 19, 2016Completed
7
Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy
Condition(s):Type 2 DiabetesLast Updated:May 6, 2013Unknown status
8
Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes
Condition(s):Diabetes Mellitus Type 1Last Updated:November 27, 2017Completed
9
CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks – A Cross-Sectional Study
Condition(s):Type 1 DiabetesLast Updated:February 19, 2016Completed
10
Individual Patient Data Meta-analysis of CSII vs. MDI in Type 2 Diabetes
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 3, 2017Completed